Eli Lilly, Novartis Could Pump Close To $3B Into AI Drug Tech

By Gianna Ferrarin · January 8, 2024, 5:31 PM EST

Eli Lilly & Co. and Novartis could invest close to $3 billion in the development of artificial intelligence for drug discovery under two new agreements with a digital biology company owned...

To view the full article, register now.